MedTech & Diagnostics
Ardent Health Executive Compensation (FY25)
ARDT · Executive and director compensation, fiscal 2023 to 2025
Chief executive, fiscal 2025 ◇ Marty Bonick | Median of the other named officers $2,064,119 5 officers, excluding the chief executive | Latest say-on-pay support = May 20, 2026 | Chief executive pay ratio ◇ To the median employee |
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.
The paid brief on Ardent Health
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Data as of October 22, 2026Latest filing (8-K): May 26, 2026
4 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Intel, one year, every company
233 figures on this page: 231 cited to the filing that reported them, 2 calculated from figures it prints. See the citations
More on Ardent Health
Five data products on this company. Each one is requested through the developer setup page.
- Peer Disclosure Audit$5The comparison companies this board named, each one tied to the filing that lists it.How to get Peer Disclosure Audit
- Governance Provisions PullfreeThe governance provisions as the proxy states them: board leadership, committee membership, and shareholder rights.How to get Governance Provisions Pull
- Say-on-Pay Risk Signal$9A risk band for the next say-on-pay vote, with the support history and the peer comparison behind it.How to get Say-on-Pay Risk Signal
- NEO Comp Report$24Every named executive officer’s pay by element and year, with the citation behind each figure.How to get NEO Comp Report
- Board Comp Report$24What each non-employee director was paid, the standing fee schedule, and the equity each one holds at year end.How to get Board Comp Report
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Marty Bonick: $6,939,257 → $6,090,004 (12.2% lower)
Say-on-pay support: 98.8% → 99.7% (0.9 points higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is Ardent Health's chief executive and what were they paid?
Marty Bonick was paid $6,090,004 in total compensation as President and Chief Executive Officer for fiscal 2025. Compared with the $6,939,257 reported for fiscal 2024, Bonick's total was 12.2% lower.
What was Ardent Health's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 99.7% of votes cast for or against in favor at the meeting held May 20, 2026.
Which companies are in Ardent Health's peer group?
The disclosed peer group names Acadia Healthcare Company, Inc., Brookdale Senior Living Inc., Community Health Systems, Inc., DaVita Inc. and Encompass Health Corp., among others.
What is Ardent Health's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 107:1, against median employee compensation of $56,682.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Marty Bonick President and Chief Executive Officer | ◇ | — | — | — | ◇ | — | ◇ | ◇ |
Alfred Lumsdaine Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Stephen Petrovich Executive Vice President and General Counsel | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
David Schultz President, Hospital Operations | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Marty Bonick President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Alfred Lumsdaine Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
David Schultz President, Hospital Operations | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Stephen Petrovich Executive Vice President and General Counsel | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Ethan Chernin President, Health Services | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Marty Bonick President and Chief Executive Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Alfred Lumsdaine Chief Financial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
David Caspers Chief Operating Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
David Schultz Former President, Hospital Operations Departed during or after this year | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Ethan Chernin Former President, Health Services Departed during or after this year | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Stephen Petrovich Executive Vice President and General Counsel | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Alfred Lumsdaine | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Alfred Lumsdaine | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| David Caspers | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| David Caspers | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| David Caspers | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| David Schultz | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| David Schultz | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Ethan Chernin | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Ethan Chernin | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Marty Bonick | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Marty Bonick | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Stephen C. Petrovich | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Stephen C. Petrovich | RSU | ◇ | — | — | ◇ | — | — | ◇ |
Fiscal 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Marty Bonick | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Stephen Petrovich | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Alfred Lumsdaine | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| David Caspers | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| Ethan Chernin | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| David Schultz | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Alfred Lumsdaine
Chief Financial Officer · Employment agreement
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
David Caspers
Chief Operating Officer · Severance agreement
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
Marty Bonick
President and Chief Executive Officer · Employment agreement
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
Stephen Petrovich
Executive Vice President and General Counsel · Employment agreement
| Severance multiple | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Mark Sotir Board chair | ◇ | ◇ | — | — | — | — | ◇ |
William Goodyear | ◇ | ◇ | — | — | — | — | ◇ |
Edmondo Robinson | ◇ | ◇ | — | — | — | — | ◇ |
Ellen Havdala | ◇ | ◇ | — | — | — | — | ◇ |
Rob Webb | ◇ | ◇ | — | — | — | — | ◇ |
Peter Bynoe | ◇ | ◇ | — | — | — | — | ◇ |
Suzanne Campion | ◇ | ◇ | — | — | — | — | ◇ |
Rahul Sen | ◇ | ◇ | — | — | — | — | ◇ |
Robert DeMichiei | ◇ | ◇ | — | — | — | — | ◇ |
Peter Bulgarelli and Marty Bonick served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Acadia Healthcare Company, Inc. ACHC
- Brookdale Senior Living Inc. BKD
- Community Health Systems, Inc. CYH
- DaVita Inc. DVA
- Encompass Health Corp. EHC
- Ensign Group, Inc. EG
- Quest Diagnostics Incorporated DGX
- Select Medical Holdings Corp. SEM
- Surgery Partners, Inc. SP
- Universal Health Services, Inc. UHS
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | May 20, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | May 21, 2025 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- Marty Bonick (President and Chief Executive Officer), FY2025 total compensation $6,090,004 (base salary $1,076,000) [exec_comp, SEC accession 0001628280-26-024244, filed 2026-04-08]What this page does not include
Everything above is a fact Ardent Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Ardent Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
233 figures on this page: 231 cited to the filing that reported them, 2 calculated from figures it prints.
231 cited to the filing
2 calculated from the filing
Documents cited
- 0001628280-26-038152Item 5.07. Submission of Matters to a Vote of Security Holders.
- 0001628280-26-024244CEO Pay Ratio · Director Compensation · Potential Payments upon Termination
- 0001628280-25-027604Item 5.07. Submission of Matters to a Vote of Security Holders.
- 0001628280-25-017085
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Ardent Health executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/ARDT (accessed 2026).
Short form: data: Velarion
The paid brief for Ardent Health
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
4 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Ardent Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
MedTech & Diagnostics rankings
Peers Ardent Health discloses
The companies named in ARDT's own disclosed peer group.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}